Cyclooxygenase-2—10 Years Later
Top Cited Papers
- 1 February 2002
- journal article
- review article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in Journal of Pharmacology and Experimental Therapeutics
- Vol. 300 (2), 367-375
- https://doi.org/10.1124/jpet.300.2.367
Abstract
The enzyme cyclooxygenase (COX) catalyzes the first step of the synthesis of prostanoids. In the early 1990s, COX was demonstrated to exist as two distinct isoforms. COX-1 is constitutively expressed as a "housekeeping" enzyme in most tissues. By contrast, COX-2 can be up-regulated by various pro-inflammatory agents, including lipopolysaccharide, cytokines, and growth factors. Whereas many of the side effects of nonsteroidal anti-inflammatory drugs (NSAIDs) (e.g., gastrointestinal ulceration and bleeding, platelet dysfunctions) are caused by a suppression of COX-1 activity, inhibition of COX-2-derived prostanoids facilitates the anti-inflammatory, analgesic, and antipyretic effects of NSAIDs. During the past few years specific inhibitors of the COX-2 enzyme have emerged as important pharmacological tools for treatment of pain and arthritis. However, although COX-2 was initially regarded as a source of pathological prostanoids only, recent studies have indicated that this isoenzyme mediates a variety of physiological responses within the organism. The present review assesses recent advances in COX-2 research, with particular emphasis on new insights into pathophysiological and physiological functions of this isoenzyme.Keywords
This publication has 70 references indexed in Scilit:
- Cyclooxygenase-2 Expression in Lipopolysaccharide-Stimulated Human Monocytes Is Modulated by Cyclic AMP, Prostaglandin E2, and Nonsteroidal Anti-inflammatory DrugsBiochemical and Biophysical Research Communications, 2000
- Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid ArthritisJama-Journal Of The American Medical Association, 2000
- Salicylate Metabolites Inhibit Cyclooxygenase-2-Dependent Prostaglandin E2 Synthesis in Murine MacrophagesBiochemical and Biophysical Research Communications, 2000
- Prostaglandin E2 Upregulates Cyclooxygenase-2 Expression in Lipopolysaccharide-Stimulated RAW 264.7 MacrophagesBiochemical and Biophysical Research Communications, 2000
- Interactions of the renin-angiotensin system and neuronal nitric oxide synthase in regulation of cyclooxygenase-2 in the macula densaActa Physiologica Scandinavica, 2000
- Effects of inhibition of prostaglandin endoperoxide synthase‐2 in chronic gastro‐intestinal ulcer models in ratsBritish Journal of Pharmacology, 1998
- Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agentsNature, 1996
- Up‐regulation of cyclooxygenase‐2 mRNA in the rat spinal cord following peripheral inflammationFEBS Letters, 1996
- Induction of cyclooxygenase-2 in human umbilical vein endothelial cells by lysophosphatidylcholine.JCI Insight, 1995
- Inhibition of NF-κB by Sodium Salicylate and AspirinScience, 1994